Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study.

Ali Al-KaabiRachel S van der PostLeonie R van der WerfBas P L WijnhovenCamiel RosmanMaarten C C M HulshofHanneke W M van LaarhovenRob H A VerhoevenPeter Derk Siersema

Published in: Acta oncologica (Stockholm, Sweden) (2021)

In this population-based study, pathological tumor response based on the ypTNM-stage was associated with different prognostic subgroups. A quarter of patients achieved ypT0N0 with favorable long-term survival, while one-third had an ypT+N+ response with very poor survival. The association between pathological tumor response and long-term survival could help in more accurate assessments of individual prognosis and treatment decisions.

Keyphrases

rectal cancer
end stage renal disease
minimally invasive
ejection fraction
locally advanced
lymph node
newly diagnosed
squamous cell carcinoma
acute coronary syndrome
radiation therapy
coronary artery bypass
peritoneal dialysis
smoking cessation
percutaneous coronary intervention
patient reported